Omicron News and Research

RSS

Pioneering AI technology can accurately detect Covid-19 in a few minutes

Pioneering Artificial Intelligence (AI) technology, developed by experts at University of the West of Scotland, is capable of accurately diagnosing Covid-19 in just a few minutes.

19 Jan 2022

Buffy Wicks turns her health history into legislation

In her short tenure as an elected official, California Assembly member Buffy Wicks hasn't been shy about sharing her most intimate health care struggles with the public.

19 Jan 2022

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

To gain a better understanding of the antigenic properties of Mu and A.2.5 Spikes, Canadian scientists evaluated their capacity to interact with ACE2 and performed binding and neutralization assays with plasma from vaccinated individuals.

18 Jan 2022

School closures for in-person learning during the pandemic have lasting effects on children

The impact virtual school had on kids goes well beyond academics, say Children's National Hospital experts in a new JAMA Pediatrics editorial.

18 Jan 2022

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

A new study that evaluated the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine against the Omicron variant indicates that three doses could offer a sufficient level of protection from disease caused by the Omicron variant.

18 Jan 2022

Feeling threatened and being informed predicted more social distancing, study shows

If the COVID-19 virus mutates beyond Omicron, getting people to practice social distancing will require more than threats about long-term health issues or death.

18 Jan 2022

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.

18 Jan 2022

Study finds COVID booster maintains strong T cell response against Omicron

New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.

18 Jan 2022

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.

18 Jan 2022

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

In a new study, a team of researchers compared the severity of the SARS-CoV-2 Omicron variant to the Delta variant using the PCR proxy marker of RNA dependent RNA polymerase target delay.

18 Jan 2022

Exploring the viral dynamics of SARS-CoV-2 Omicron variant

In a new study, researchers posted findings in which they investigated the viral dynamics of the SARS-CoV-2 Omicron variant.

18 Jan 2022

Dynamics of outbreaks of SARS-CoV-2 variants of concern

In a new study, researchers characterized the features of the outbreak duration of the novel SARS-CoV-2 variants of concern.

18 Jan 2022

Study shows several low- and middle-income countries at over 50% risk of undetected Omicron transmission

In a new study, researchers estimated the probability of undetected emergence of the SARS-CoV-2 Omicron variant in 25 low and middle-income countries by early December 2021.

18 Jan 2022

Forecasting the temporal evolution of Omicron infections

In a new study, researchers estimated the rate of SARS-CoV-2 Omicron infections by modeling temporal evolution of the Omicron wave.

18 Jan 2022

Officials struggle to regulate pop-up covid testing sites — and warn patients to beware

In recent months, mobile covid-19 testing tents and vans have sprouted on urban sidewalks and street curbs as demand has skyrocketed in response to the rapid spread of the omicron variant.

18 Jan 2022

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

In a new study, researchers analyzed the neutralization of SARS-CoV-2 Omicron and D614G variants before and after subjects received COVID-19 booster vaccinations.

18 Jan 2022

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

18 Jan 2022

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

18 Jan 2022

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

A recent study has reported a community outbreak of imported SARS-CoV-2 Beta variant, owing to intra-hotel transmission in a DQH.

17 Jan 2022

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Researchers compare the outcomes of the fourth and previous waves of the COVID-19 pandemic in South Africa.

17 Jan 2022

Omicron News and Research

Pioneering AI technology can accurately detect Covid-19 in a few minutes

Buffy Wicks turns her health history into legislation

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

School closures for in-person learning during the pandemic have lasting effects on children

Three doses Of Pfizer-BioNTech vaccine could offer sufficient level of protection from Omicron

Feeling threatened and being informed predicted more social distancing, study shows

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Study finds COVID booster maintains strong T cell response against Omicron

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

Exploring the viral dynamics of SARS-CoV-2 Omicron variant

Dynamics of outbreaks of SARS-CoV-2 variants of concern

Study shows several low- and middle-income countries at over 50% risk of undetected Omicron transmission

Forecasting the temporal evolution of Omicron infections

Officials struggle to regulate pop-up covid testing sites — and warn patients to beware

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

Immune responses in Omicron breakthrough COVID-19

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News